Metabolomics Market is segmented by Product & Service Type (Metabolomics Instruments, Metabolomics Bioinformatics Tools and Services), Clinical Indication Type (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others), Application Type (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Others), End-User Type (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Institutions, Others), Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The U.K., Russia, and Rest of Europe], Asia-Pacific [China, Japan, India, South Korea, and Rest of Asia-Pacific], and Rest of the World [Brazil, Saudi Arabia, Israel, and Others]).